Found 0 matching trials
Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
PHASE2The purpose of this study is to assess the safety and immunogenicity of ame...
Status
Active Not Recruiting
Location
Curevo Investigational Site
Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
PHASE2To evaluate the immunogenicity of the investigational product (IP) in healt...
Location
Kyungpook National University Chilgok Hospital
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
PHASE4Introduction: Patients with autoimmune rheumatic diseases (ARDs), rheumatoi...
Status
Active Not Recruiting
Location
Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo
The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)
PHASE1This is a randomized, observer-blinded, active-controlled Phase I study to ...
Location
Pharma Peak Research Philippines,Inc.
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
PHASE1This clinical trial included two parts, Part A and Part B. The goal of Part...
Location
Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention
Shingrix In Recipients of Allogeneic Transplants
PHASE2This research is designed to determine if the adjuvanted recombinant glycop...
Location
University of Colorado Hospital
Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
PHASE1The purpose of this study is to evaluate the safety and immunogenicity of t...
Location
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
PHASE2Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by prog...
Location
Ministry of Health Medical City
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
PHASE1This is a randomized, active-controlled, observer-blinded, dose-escalation ...
Status
Active Not Recruiting
Location
Paratus Clinical Research Western Syndney
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
PHASE2The goal of this clinical trial is to assess the safety and immunogenicity ...
Status
Active Not Recruiting
Location
Noble Clinical Research